🌍·Jul 15Industry
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
Publisher
A
Allogene Therapeutics
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Allogene Therapeutics
- Region
- Global
- Scope
- Industry
- Published
- July 15, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ir.allogene.com
Leave the platform to read the original full article on the publisher site.
Source: Allogene Therapeutics
Scope: Industry
Related coverage
More related coverage
Codexis/9h ago
Codexis Announces Pricing of Public Offering of Common Stock
Aspen Pharmacare/1h ago
Strengthening partnerships, visibility and sustainable progress in the CDMO space
Nippon Shinyaku News/1h ago
「第97回 都市対抗野球大会」組み合わせ決定 日本新薬は鹿嶋市代表「日本製鉄鹿島」と対戦
Merck & Co. (MSD) News/2h ago